Pharmakon Advisors
Overview
Pharmakon Advisors, LP is an investment management firm founded in 2009 that specializes in providing debt financing to the life sciences industry, including biotechnology, pharmaceuticals, and medical technology companies. The firm acts as the investment manager for the BioPharma Credit funds, which include private funds and a publicly traded UK trust, BioPharma Credit PLC (LSE: BPCR). Pharmakon focuses on non-dilutive debt capital, investing in debt securities and royalty-backed instruments. The firm has committed over $10 billion across more than 60 transactions since its inception.
Portfolio Companies
2
Website
pharmakonadvisors.comInvestments
| Company | Date | Stage | Lead |
|---|---|---|---|
| BRAINBox Solutions | Dec 2020 | Series A | Co-investor |
| Optune | May 2024 | Debt | Lead |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Pharmakon Advisors based?
Pharmakon Advisors is headquartered in New York City, New York, United States.
When was Pharmakon Advisors founded?
Founding year information for Pharmakon Advisors is not publicly available.
How many portfolio companies does Pharmakon Advisors have?
Pharmakon Advisors has 2 portfolio companies in Caplight's dataset.
What are some companies in Pharmakon Advisors's portfolio?
Portfolio companies visible on Caplight include BRAINBox Solutions, Optune.
What was Pharmakon Advisors's most recent investment shown here?
Pharmakon Advisors's most recent investment in this portfolio sample was in Optune in 2024.
What sectors does Pharmakon Advisors focus on?
Pharmakon Advisors focuses on Healthcare & Life Sciences, Enterprise Software, Media, Entertainment & Gaming.
What company stages does Pharmakon Advisors focus on?
Pharmakon Advisors typically invests at the Early stage.
What is Pharmakon Advisors's AUM?
Pharmakon Advisors's assets under management are estimated between $2.9B and $2.9B.